GlassScriptPhysician profile
Nicole D King
NPI 1558334003
$2,072.05
in general payments reported to CMS, 2019-2025
17 companies · $567 in 2025
The $567 reported for 2025 was more than what 76% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $61.11 · 2021: $84.53 · 2022: $313 · 2023: $565 · 2024: $481 · 2025: $567.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,594 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,593.62 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $677.99 | 2021-2025 | Mounjaro, Zepbound, Kisunla |
| Astrazeneca Pharmaceuticals LP | $529.25 | 2021-2025 | Farxiga, Lynparza, Breztri |
| Novo Nordisk INC | $176.92 | 2023-2025 | Ozempic, Rybelsus |
| Bayer Healthcare Pharmaceuticals INC. | $109.84 | 2024-2025 | |
| Amgen INC. | $108.89 | 2025 | Repatha, Otezla |
| Gilead Sciences, INC. | $107.97 | 2023 | |
| Eisai INC. | $65.90 | 2024-2025 | |
| Currax Pharmaceuticals LLC | $63.19 | 2022 | |
| Novartis Pharmaceuticals Corporation | $52.56 | 2022-2023 | |
| Pfizer INC. | $29.77 | 2020 | |
| Tactile Systems Technology INC | $28.59 | 2025 | Flexitouch Plus, Nimbl |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $27.50 | 2020-2025 | Xifaxan |
| Irhythm Technologies, INC. | $23.89 | 2024 | Zio At Patch |
| Kowa Pharmaceuticals America, INC. | $21.26 | 2024 | Zoryve |
| Sanofi-Aventis U.S. LLC | $18.87 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $16.25 | 2023 | Cologuard Collection Kit |
| Phadia US INC. | $13.41 | 2023 | Immunocap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.